The Center for Digital Pathology brings together Johns Hopkins University pathologists, clinicians and engineers to develop, validate and apply novel multi-parametric pathological tools for enhanced pathological assessments of patients.
To improve the diagnostic and prognostic of human diseases, including cancer, cardiovascular disease, COPD, as well as CNS, autoimmune and metabolic diseases.
- Develop, validate, and use novel, integrated techniques in imaging and “omic” approaches (genomics, epigenomics, proteomics, etc.) for the combined molecular and phenotypic characterization of diseased tissues and cells at single-cell resolution.
- Create platforms that will provide patients and clinicians with highly personalized medicine, specifically enhanced therapeutic matching, precise determination of survival and robust prediction of drug response and drug resistance.
Denis Wirtz, PhD
Theophilus H. Smoot Professor in the Department of Chemical and Biomolecular Engineering in the Johns Hopkins Whiting School of Engineering; associate director of the Johns Hopkins Institute for NanoBioTechnology; director of the Johns Hopkins Engineering in Oncology Center (an NCI Physical Sciences-Oncology Center).
Ralph Hruban, MD
Professor in the departments of Pathology and Oncology, and director of the Sol Goldman Pancreatic Cancer Research Center at the Johns Hopkins School of Medicine; director of the Division of Gastrointestinal/Liver Pathology and deputy director of Program and Research in the Pathology Department.
Anirban Maitra, MBBS
Professor in the departments of Pathology and Oncology at the Sol Goldman Pancreatic Cancer Research Center in the Johns Hopkins School of Medicine; affiliate faculty at the McKusick-Nathans Institute of Genetic Medicine.